Cabot Reports Q1 FY26 Adjusted EPS Decline, Narrows Lower Full-Year Guidance
CBT sits 22% above its 52-week low of $58.33.
Summary
Cabot Corporation reported a 13% year-over-year decrease in Q1 FY26 Adjusted EPS and issued lower full-year guidance, but also announced a significant multi-year supply agreement for EV battery materials.
Key Events · Earnings and Guidance · CBT
-
Q1 FY26 Adjusted EPS Decline
Reported Adjusted EPS of $1.53, a 13% decrease compared to $1.76 in the prior year, primarily due to lower volumes in the Reinforcement Materials segment.
-
Lower Full-Year Guidance
Narrows full-year fiscal 2026 Adjusted EPS guidance to $6.00-$6.50 per share, a reduction from the $7.25 reported in fiscal 2025.
-
Strategic EV Battery Supply Agreement
Signed a multi-year deal with PowerCo SE to supply conductive carbons and dispersions for lithium-ion battery applications, reinforcing its leadership in battery materials.
-
Mixed Segment Performance
Reinforcement Materials EBIT decreased 22% year-over-year, while Performance Chemicals EBIT increased 7% driven by favorable product mix and battery materials strength.
Analysis · CBT · Industrial Applications And Services
Cabot Corporation's first-quarter fiscal year 2026 results reveal a mixed financial performance, with Adjusted EPS declining 13% year-over-year, primarily due to significant volume reductions in the Reinforcement Materials segment. The company also narrowed its full-year Adjusted EPS guidance to $6.00-$6.50, which is notably lower than the $7.25 reported for fiscal year 2025, indicating a challenging outlook. However, the Performance Chemicals segment showed growth, bolstered by a new multi-year supply agreement with PowerCo SE for EV battery materials. This strategic deal is a significant positive for Cabot's long-term growth in a key market, partially offsetting the immediate financial headwinds. Investors will need to balance the current quarter's earnings weakness and the reduced full-year outlook against the promising strategic advancements in battery materials.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CBT was trading at $71.20 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $58.33 to $89.16. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.